PURPOSE: Cardiovascular magnetic resonance (CMR) is considered the standard imaging modality in clinical trials to monitor patients after acute myocardial infarction (AMI). However, limited data is available with respect to infarct size, presence, and extent of microvascular injury (MVO), and changes over time, in relation to cardiac function in these optimally treated patients. In this study, we prospectively investigate the change of infarct size over time, and the incidence and significance of MVO in a uniform, optimally treated patient group after AMI. METHODS: Forty patients underwent cine and late gadolinium-enhanced CMR within 9 days and at 4 months after primary stenting. Left ventricular ejection fraction (LVEF), infarct size (IS) and MVO size were calculated. RESULTS: IS decreased with 19.0% at follow-up (p<0.01). The 23 (57.5%) patients with MVO had larger infarct size, higher left ventricular volumes and lower LVEF and more involution of IS at follow-up. Overall, LVEF improved from 42.3+/-9.8% to 44.0+/-9.8% (p=0.06), irrespective of presence or size of MVO. CONCLUSION: Infarct size reduces over time by 19.0% in optimally treated patients after AMI. Despite optimal reperfusion, MVO was found in the majority of patients. Although patients with MVO had larger infarcts and worse indices of left ventricular remodelling, functional change at follow-up was comparable to patients without MVO.
PURPOSE: Cardiovascular magnetic resonance (CMR) is considered the standard imaging modality in clinical trials to monitor patients after acute myocardial infarction (AMI). However, limited data is available with respect to infarct size, presence, and extent of microvascular injury (MVO), and changes over time, in relation to cardiac function in these optimally treated patients. In this study, we prospectively investigate the change of infarct size over time, and the incidence and significance of MVO in a uniform, optimally treated patient group after AMI. METHODS: Forty patients underwent cine and late gadolinium-enhanced CMR within 9 days and at 4 months after primary stenting. Left ventricular ejection fraction (LVEF), infarct size (IS) and MVO size were calculated. RESULTS: IS decreased with 19.0% at follow-up (p<0.01). The 23 (57.5%) patients with MVO had larger infarct size, higher left ventricular volumes and lower LVEF and more involution of IS at follow-up. Overall, LVEF improved from 42.3+/-9.8% to 44.0+/-9.8% (p=0.06), irrespective of presence or size of MVO. CONCLUSION:Infarct size reduces over time by 19.0% in optimally treated patients after AMI. Despite optimal reperfusion, MVO was found in the majority of patients. Although patients with MVO had larger infarcts and worse indices of left ventricular remodelling, functional change at follow-up was comparable to patients without MVO.
Authors: Dennis T L Wong; Michael C H Leung; James D Richardson; Rishi Puri; Angela G Bertaso; Kerry Williams; Ian T Meredith; Karen S L Teo; Matthew I Worthley; Stephen G Worthley Journal: Int J Cardiovasc Imaging Date: 2012-02-05 Impact factor: 2.357
Authors: Dennis T L Wong; Michael J Weightman; Mathias Baumert; Hussam Tayeb; James D Richardson; Rishi Puri; Angela G Bertaso; Kurt C Roberts-Thomson; Prashanthan Sanders; Matthew I Worthley; Stephen G Worthley Journal: Eur Radiol Date: 2012-03-27 Impact factor: 5.315
Authors: R Nijveldt; A M Beek; A Hirsch; M B M Hofman; V A W M Umans; P R Algra; A C van Rossum Journal: Neth Heart J Date: 2008-05 Impact factor: 2.380
Authors: Dennis T L Wong; Darryl P Leong; Michael J Weightman; James D Richardson; Benjamin K Dundon; Peter J Psaltis; Michael C H Leung; Ian T Meredith; Matthew I Worthley; Stephen G Worthley Journal: Eur Radiol Date: 2014-04-12 Impact factor: 5.315